-
Impact of device-aided therapies on QoL and Off-time improvement in advanced Parkinson’s Disease patients: Comparative effectiveness results from a Bayesian Network Meta-Analysis
-
Impact of Disease Severity on Presentation Subtype and OnabotulinumtoxinA Utilization in Patients with Cervical Dystonia: Results from the CD PROBE Completer Population
-
Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.
-
Impact of Restless Leg Syndrome (RLS) Severity on Cognitive Function and Depression
-
Impact of specialized light therapy in Parkinson’s disease on MDS-UPDRS parts 1-3 subscales
-
IMPACT OF STANDARD-OF-CARE MEDICATIONS ON TIME-OFF READOUTS IN CLINICAL TRIALS. A QUANTITATIVE SYSTEMS PHARMACOLOGY APPROACH
-
Impact of the postural function сhanges on quality of life and daily activity in patients with Parkinson’s disease during DBS
-
Impact on Dyskinesia in Advanced Parkinson’s Disease Patients Treated with LCIG: Analysis from the COSMOS Study
-
Impacts of Tardive Dyskinesia (TD) Symptoms on Patients: Analysis of a TD-Specific Patient-Reported Outcome
-
Impaired glucocerebrosidase transport to lysosomes in cultured macrophages derived from blood monocytic cells of patients with Parkinson’s disease associated with mutations in the GBA gene
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 132
- Next Page »